Clinical data speaks dozens of languages. Ontologies are the translator. Discover how life sciences teams are using semantic layers, AI agents, and MCP connectors to cut months of data harmonization down to days.

AI-powered remote patient monitoring (RPM) is transforming clinical trials by enabling continuous data collection, real-time insights, and decentralized participation. This ecosystem spans wearables, AI analytics, data platforms, and decentralized clinical trial (DCT) infrastructure.

Additionally, agentic AI is fundamentally reshaping remote patient monitoring (RPM) in clinical trials by shifting it from passive data collection to proactive, autonomous decision support. Instead of simply aggregating data from wearables and patient-reported outcomes, agentic systems can continuously analyze multi-source trial data, identify emerging risks, and take action, such as prioritizing at-risk patients or sites, triggering alerts, or recommending interventions, without waiting for human input. This significantly reduces delays in detecting safety signals or protocol deviations. Just as importantly, agentic AI introduces workflow automation at scale by handling routine monitoring tasks, coordinating communications, and maintaining audit-ready reasoning trails. The result is a more adaptive and responsive RPM model where clinical teams move from manual oversight to strategic supervision, enabling faster, safer, and more efficient trials.

Below is a structured overview of the leading vendors, tools, and providers enabling AI-driven RPM in clinical research.

‍

Medable’s clinical trial platform leverages a robust network of connectors to integrate seamlessly with the systems that power study execution, from EDC and CTMS to collaboration and data platforms. These connectors enable AI to operate across workflows in real time, unifying data, automating processes, and improving coordination across team

‍

‍